| Jun 18, 2012
| 5:15 AM
Is there no limit to what people will tolerate in the name of "educational reform" ("Biosensors to monitor students' attentiveness," June 12)?
Making children wear "biosensor bracelets" to see if they are paying attention in school is an outrage, an...
| Jun 24, 2012
| 2:46 PM
If he's doing his job, an NFL official will largely go unnoticed. He will make sure the rules are followed, of course, yet blend into the background as much as possible.
Tony Corrente is anything but invisible.
The longtime NFL referee learned that as...
| Oct 9, 2012
| 9:45 AM
The American Cancer Society Cancer Action Network applauds the work of the Maryland General Assembly in passing the Kathleen Mathias Oral Chemotherapy Act of 2012. The provisions of the bill went into effect Oct. 1, resulting in increased quality of...
| Oct 20, 2012
| 1:44 PM
If there ever was a right time to be diagnosed with breast cancer, Beth Thompson found one.
In February 2006, the pea-size tumor in her right breast was too small for a clinical trial of Herceptin, a targeted therapy that had proved effective in advanced...
| Jun 28, 2012
| 1:03 PM
Only months after he moved away to start a career in Phoenix, Ariz., longtime Lansdowne community activist Brian Bailey has returned to the area. The 27-year-old former president of the Lansdowne Improvement Association is back to receive cancer treatment...
| Jun 28, 2012
| 8:24 PM
The Supreme Court's ruling on President Barack Obama's health care initiative was a cause for great anticipation for Alicia Steinberg.
In the parking lot of Brown Memorial Woodbrook Church on Thursday, the West Towson resident was waiting until the...
| Jul 13, 2012
| 5:56 PM
Vince Demor walked through a hotel lobby in shorts and a T-shirt, looking like any teenager, except for the accordion around his neck, which he wore as naturally as a lawyer sports a tie. He played exercises quietly as he walked.
Accordions are all...
| Oct 18, 2012
| 8:22 AM
It is well documented that African-American women with breast cancer are more likely to have a more aggressive type of the disease that kills them, but why remains a mystery.
The answers may be found one day soon, as researchers focus more on the genetic...
| Jul 13, 2012
| 6:04 AM
The audience at Hereford High School's graduation at McDaniel College in Westminster on May 25 was asked to hold applause until the names of all graduates had been read and diplomas awarded.
There were occasional bursts of clapping, some hoots and some...
| Jul 16, 2012
| 4:00 PM
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...
| Jul 30, 2012
| 4:17 PM
Columbia-based Osiris Therapeutics Inc., a biotechnology company developing stem cell-based treatments, beat Wall Street analysts' estimates with a reported loss of $4.3 million in the second quarter, which ended June 30.
The firm, which earlier this...
| Aug 10, 2012
| 5:41 PM
Baltimore BioWorks is John Powers's third biotech company — and the one that he says he's most excited about.
The 56-year-old Ellicott City doctor built a career in biotechnology, working for the Centers for Disease Control and the National...